Quick Takeaways
- BLFS - BIOLIFE SOLUTIONS INC financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q1 2026.
- Headline metric: Return On Equity -1.3%.
- Info
- Insider Trading
- Financials
- Holders
BIOLIFE SOLUTIONS INC financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.
- Symbol
- BLFS on Nasdaq
- Location
- Bothell, WA
- Fiscal year end
- 31 December
- Latest financial report
- 26 Feb 2026
What Changed
- Return On Equity YoY change: <span class="text-red-600">-78%</span>.
- Most recent SEC facts end date: 19 Feb 2026.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original FilingLatest SEC snapshot (2026-02-19) highlights Return On Equity -1.3%, Return On Assets -1.1%, and Current Ratio 5.94x.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
47.3/100
Caution Confidence medium
Return On Equity
-1.3%
Metric score 0.0/100
Return On Assets
-1.1%
Metric score 0.0/100
Financial Health
- Current Ratio
- 5.94x
- Quick Ratio
- 1.78x
- Debt to Equity
- 0.11x
Strengths
Quick Ratio, Debt-to-equity, and NetIncomeLoss YoY
Watchpoints
Return On Equity, Return On Assets, and Current Ratio
Key metrics snapshot
Return On Equity
-1.3%
YoY: -78%
Industry median: -2.4% (n=46)
Return On Assets
-1.1%
YoY: -77%
Industry median: -38% (n=46)
Current Ratio
5.94x
YoY: +31%
Industry median: 1.7x (n=46)
Quick Ratio
1.78x
YoY: -50%
Industry median: 1.04x (n=38)
Debt-to-equity
0.11x
YoY: -37%
Industry median: 0.8x (n=33)
NetIncomeLoss YoY
77%
YoY:
Industry median: -12% (n=45)
Profitability
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Equity | -1.3% | -78% |
| Return On Assets | -1.1% | -77% |
Financial Health
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 5.94x | +31% |
| Quick Ratio | 1.78x | -50% |
| Debt-to-equity | 0.11x | -37% |
Growth
| Metric | Latest value | YoY change |
|---|---|---|
| NetIncomeLoss YoY | 77% |
Share Metrics
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 48,300,000 | +1.7% |
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY